Filter By Industry
Filter By Tag

Newsroom

Spherium Biomed SL Press releases

1 - 1 of 1 Press Release

Spherium Biomed enrolls first patient in efficacy trial for SP13004 for prevention & treatment of chemoradiation-induced mucositis
Nov 17, 2015
The Phase IB-II clinical trial is designed to investigate the safety, tolerability, pharmacokinetics and efficacy of SP13004 for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing chemoradiation.


Spherium Biomed SL RSS Feed